Jgp Global Gestao De Recursos Ltda. Madrigal Pharmaceuticals, Inc. Transaction History
Jgp Global Gestao De Recursos Ltda.
- $146 Million
- Q4 2025
A detailed history of Jgp Global Gestao De Recursos Ltda. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Jgp Global Gestao De Recursos Ltda. holds 625 shares of MDGL stock, worth $330,756. This represents 0.23% of its overall portfolio holdings.
Number of Shares
625
Previous 1,042
40.02%
Holding current value
$330,756
Previous $477,000
30.82%
% of portfolio
0.23%
Previous 0.28%
Shares
8 transactions
Others Institutions Holding MDGL
# of Institutions
412Shares Held
23MCall Options Held
665KPut Options Held
514K-
Baker Bros. Advisors LP New York, NY2.14MShares$1.13 Billion8.0% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$1.06 Billion12.22% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.91MShares$1.01 Billion31.28% of portfolio
-
Janus Henderson Group PLC London, X01.84MShares$975 Million0.41% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.83MShares$970 Million11.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $9.05B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...